Stay updated with breaking news from Generics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, U.S., effective from September 1, 2023.
Biotechnology major Biocon on Saturday said its unit has acquired Eywa Pharma Inc's oral solid dosage manufacturing facility in the US for USD 7.7 million (over Rs 63 crore). Biocon Generics Inc has acquired Eywa's ranbury-based plant effective September 1 2023, the Bengaluru-based company